SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NTEG- Bloodless Glucose Monitor
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tevyah who wrote (2)12/20/1996 11:34:00 AM
From: Jim Lovejoy   of 176
 
The principle upon which their device is based is the same as two other
companys' (Cygnus & a private company that recently partnered with Abbott's
Labs). It is based on fact? that intercellular fluid has glucose level
that coresponds really well with blood glucose, and is a *whole* lot easier
to get. The three companies (apparantly) have different methods
of getting the fluid.

Nteg's specifics was filed with SEC (in prospectus?), EDGAR has it,
but it is *Huge* file, and you still have to find specifics.

Hope this helps.

JL
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News